Acesso livre
Acesso livre

Gastroenterologia

Diretriz de Consenso | U.S. Multi-Society Task Force sobre câncer colorretal agora sugere que o rastreamento da doença comece aos 45 anos de idade.

22 Nov, 2021 | 09:30h

Updates on Age to Start and Stop Colorectal Cancer Screening: Recommendations From the U.S. Multi-Society Task Force on Colorectal Cancer – Gastroenterology

Comunicado de imprensa: US Multi-Society Task Force on colorectal cancer releases updated screening recommendations - American Gastroenterological Association

Conteúdos relacionados:

State of the Art Review: Screening and prevention of colorectal cancer.

USPSTF Statement: Start colorectal cancer screening at 45 years for most patients.

ACG Clinical Guidelines: Start colorectal cancer screening at 45

Destaques de diretriz clínica para o hospitalista | Tratamento do sangramento gastrintestinal alto e úlcera.

22 Nov, 2021 | 09:13h

Clinical Guideline Highlights for the Hospitalist: Management of Upper Gastrointestinal and Ulcer Bleeding – Journal of Hospital Medicine (gratuito por tempo limitado)

Diretriz original: ACG Clinical Guideline: Upper Gastrointestinal and Ulcer Bleeding – RBC transfusion at a threshold of 7 g/dL; Erythromycin infusion is suggested before endoscopy; and endoscopy is suggested within 24 hours after presentation.

Revisão e algoritmo: disfagia aórtica.

16 Nov, 2021 | 12:23h

Dysphagia aortica – European Surgery

Estudo de coorte | Em pacientes com esteato-hepatite não alcoólica e obesidade, a cirurgia bariátrica foi associada com menor risco de incidência de desfechos adversos hepáticos maiores e eventos cardiovasculares maiores.

12 Nov, 2021 | 13:33h

Association of Bariatric Surgery With Major Adverse Liver and Cardiovascular Outcomes in Patients With Biopsy-Proven Nonalcoholic Steatohepatitis – JAMA (gratuito por tempo limitado)

Editorial: Bariatric Surgery as a Strategy for Improving Outcomes in Nonalcoholic Steatohepatitis – JAMA (gratuito por tempo limitado)

 

Comentário no Twitter

 

Consenso | Avanço na agenda de saúde pública global para doença hepática gordurosa não alcoólica.

11 Nov, 2021 | 16:15h

Advancing the global public health agenda for NAFLD: a consensus statement – Nature Reviews Gastroenterology & Hepatology

Conteúdos relacionados:

Clinical Care Pathway for the Risk Stratification and Management of Patients with Nonalcoholic Fatty Liver Disease.

Non-alcoholic fatty liver disease: A patient guideline.

State of the art review: Management of non-alcoholic fatty liver disease

M-A: Non-alcoholic fatty liver disease linked to increased risk of fatal and non-fatal cardiovascular events.

M-A: non-invasive tests for advanced fibrosis can reduce the need for biopsy in patients with non-alcoholic fatty liver disease.

Review: Dietary carbohydrates and fats in nonalcoholic fatty liver disease.

 

Comentário no Twitter

 

Estudo randomizado | Rastreamento com sigmoidoscopia flexível uma única vez está associado com redução, no longo prazo, da incidência e mortalidade por câncer colorretal.

10 Nov, 2021 | 12:41h

Long-Term Follow-up of the Italian Flexible Sigmoidoscopy Screening Trial – Annals of Internal Medicine

Comentários:

Flexible sigmoidoscopy associated with long-term reduction in colorectal cancer incidence, mortality – ACP Internist

Flexible sigmoidoscopy screening associated with long-term reduction in colorectal cancer incidence and mortality – American College of Physicians

Cuidados clínicos na estratificação de risco e tratamento de pacientes com doença hepática gordurosa não alcoólica.

5 Nov, 2021 | 17:12h

Clinical Care Pathway for the Risk Stratification and Management of Patients With Nonalcoholic Fatty Liver Disease – Gastroenterology

Comunicado de imprensa: International experts develop Clinical Care Pathway in response to NASH epidemic – American Gastroenterology Association

Conteúdos relacionados:

Non-alcoholic fatty liver disease: A patient guideline.

State of the art review: Management of non-alcoholic fatty liver disease

M-A: Non-alcoholic fatty liver disease linked to increased risk of fatal and non-fatal cardiovascular events.

M-A: non-invasive tests for advanced fibrosis can reduce the need for biopsy in patients with non-alcoholic fatty liver disease.

Review: Dietary carbohydrates and fats in nonalcoholic fatty liver disease.

Revisão | Tratamento do distúrbio de uso do álcool em pacientes com cirrose num contexto de transplante hepático.

3 Nov, 2021 | 11:02h

Management of alcohol use disorder in patients with cirrhosis in the setting of liver transplantation – Nature Reviews Gastroenterology & Hepatology

 

Comentário no Twitter

 

Diretriz de Consenso | Abordagem pré-operatória de medicações gastrintestinais e pulmonares.

2 Nov, 2021 | 12:28h

Preoperative Management of Gastrointestinal and Pulmonary Medications: Society for Perioperative Assessment and Quality Improvement (SPAQI) Consensus Statement – Mayo Clinic Proceedings

Artigos relacionados da Mayo Clinic Proceedings:

Consensus Statement: Preoperative management of endocrine, hormonal, and urologic medications

Consensus statement: Preoperative management of opioid and nonopioid analgesics

Perioperative evaluation and management of patients with diabetes, thyroid disease, and adrenal insufficiency. Use of insulin and noninsulin diabetic medications, management of hyper and hypothyroidism, and use of stress-dose corticosteroids are some of the subjects reviewed

Review: Preoperative Cardiac Risk Assessment

Review | Perioperative cardiac risk reduction in noncardiac surgery.

Systematic Review of Perioperative Cardiac Risk Prediction Indices

Review: Perioperative venous thromboembolism prophylaxis

Revisão | Neurotoxicidade induzida por metronidazol.

2 Nov, 2021 | 12:15h

Metronidazole-induced neurotoxicity – Canadian Medical Association Journal

 

Comentário no Twitter

 

Mantenha-se atualizado em sua especialidade

 

Escolha quantas especialidades quiser.